[PDF][PDF] 3.3 Third work “Correlation between early trends of a prognostic biomarker and overall survival in non-small-cell lung cancer clinical trials”

H Loureiro, TM Kolben, A Kiermaier, D Rüttinger… - The future of clinical …, 2024‏ - d-nb.info
Results The sign of the risk trend (𝛽2 coefficient) was concordant with the final OS effect for
11 out of 12 clinical trials. The only exception was PRONOUNCE, where the Carboplatin+ …